Moreover, preparations of a weak TLR4 agonist MPLA (or its synthetic analogue GLA) restored the intratumoral activity of cytotoxic T cells and elevated pulmonary NK cell cytotoxicity, which led to tumor eradication and a reduction in cancer metastasis [119,139]. This evidence concerns the gene TLR4 and cancer.